{"id":"https://openalex.org/W1994145229","doi":"https://doi.org/10.1111/j.1365-2826.2008.01681.x","title":"CB1 Receptor Blockade and its Impact on Cardiometabolic Risk Factors: Overview of the RIO Programme with Rimonabant","display_name":"CB1 Receptor Blockade and its Impact on Cardiometabolic Risk Factors: Overview of the RIO Programme with Rimonabant","publication_year":2008,"publication_date":"2008-04-17","ids":{"openalex":"https://openalex.org/W1994145229","doi":"https://doi.org/10.1111/j.1365-2826.2008.01681.x","mag":"1994145229","pmid":"https://pubmed.ncbi.nlm.nih.gov/18426513"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2826.2008.01681.x","doi":"https://doi.org/10.1111/j.1365-2826.2008.01681.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2826.2008.01681.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2826.2008.01681.x","source":{"id":"https://openalex.org/S100175869","display_name":"Journal of Neuroendocrinology","issn_l":"0953-8194","issn":["0953-8194","1365-2826"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neuroendocrinology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2826.2008.01681.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039563874","display_name":"Andr\u00e9 Jacques Scheen","orcid":"https://orcid.org/0000-0001-9743-4371","observed_orcids":["https://orcid.org/0000-0001-9743-4371"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]},{"id":"https://openalex.org/I4210134544","display_name":"Centre Hospitalier Universitaire de Li\u00e8ge","ror":"https://ror.org/044s61914","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210134544"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"A. J. Scheen","raw_affiliation_strings":["Division of Diabetes, Nutrition and Metabolic Disorders and Clinical Pharmacology Unit, CHU Sart Tilman, University of Liege, Liege, Belgium. andre.scheen@chu.ulg.ac.be","Division of Diabetes, Nutrition and Metabolic Disorders and Clinical Pharmacology Unit, CHU Sart Tilman, University of Liege, Liege, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Diabetes, Nutrition and Metabolic Disorders and Clinical Pharmacology Unit, CHU Sart Tilman, University of Liege, Liege, Belgium. andre.scheen@chu.ulg.ac.be","institution_ids":["https://openalex.org/I157674565"]},{"raw_affiliation_string":"Division of Diabetes, Nutrition and Metabolic Disorders and Clinical Pharmacology Unit, CHU Sart Tilman, University of Liege, Liege, Belgium","institution_ids":["https://openalex.org/I157674565","https://openalex.org/I4210134544"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5039563874"],"corresponding_institution_ids":["https://openalex.org/I157674565","https://openalex.org/I4210134544"],"apc_list":{"value":4550,"currency":"USD","value_usd":4550},"apc_paid":null,"fwci":7.815,"has_fulltext":true,"cited_by_count":69,"citation_normalized_percentile":{"value":0.9775,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"20","issue":"s1","first_page":"139","last_page":"146"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10414","display_name":"Cannabis and Cannabinoid Research","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rimonabant","display_name":"rimonabant","score":1.0},{"id":"https://openalex.org/keywords/cb1-receptor-antagonism","display_name":"CB1 receptor antagonism","score":0.8619999885559082},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.5479999780654907},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8889999985694885},{"id":"https://openalex.org/keywords/cardiometabolic-risk-factors","display_name":"cardiometabolic risk factors","score":0.9190000295639038},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8270000219345093},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.843999981880188},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.7490000128746033},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.7699999809265137},{"id":"https://openalex.org/keywords/adiponectin","display_name":"adiponectin","score":0.9359999895095825},{"id":"https://openalex.org/keywords/small-dense-ldl","display_name":"small dense LDL","score":0.7799999713897705},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8809999823570251},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.7820000052452087},{"id":"https://openalex.org/keywords/antidepressant-safety","display_name":"antidepressant safety","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C2776433454","wikidata":"https://www.wikidata.org/wiki/Q412529","display_name":"Rimonabant","level":5,"score":0.9754226803779602},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8013448715209961},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6842061281204224},{"id":"https://openalex.org/C2780586474","wikidata":"https://www.wikidata.org/wiki/Q332428","display_name":"Overweight","level":3,"score":0.6648712158203125},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6182511448860168},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.604117751121521},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5818442702293396},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.4613926410675049},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.44660383462905884},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.43770474195480347},{"id":"https://openalex.org/C2776782570","wikidata":"https://www.wikidata.org/wiki/Q357439","display_name":"Adiponectin","level":4,"score":0.4116341471672058},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.40376016497612},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.32478269934654236},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.22518643736839294},{"id":"https://openalex.org/C148001335","wikidata":"https://www.wikidata.org/wiki/Q421237","display_name":"Cannabinoid receptor","level":4,"score":0.19640865921974182},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06282222270965576},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077285","descriptor_name":"Rimonabant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019440","descriptor_name":"Anti-Obesity Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D024821","descriptor_name":"Metabolic Syndrome","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D043884","descriptor_name":"Receptor, Cannabinoid, CB1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D043884","descriptor_name":"Receptor, Cannabinoid, CB1","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1365-2826.2008.01681.x","doi":"https://doi.org/10.1111/j.1365-2826.2008.01681.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2826.2008.01681.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2826.2008.01681.x","source":{"id":"https://openalex.org/S100175869","display_name":"Journal of Neuroendocrinology","issn_l":"0953-8194","issn":["0953-8194","1365-2826"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neuroendocrinology","raw_type":"journal-article"},{"id":"pmid:18426513","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18426513","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neuroendocrinology","raw_type":"Evaluation Study"},{"id":"pmh:oai:orbi.ulg.ac.be:2268/4256","doi":null,"is_oa":true,"landing_page_url":"https://orbi.uliege.be/handle/2268/4256","pdf_url":"https://orbi.uliege.be/bitstream/2268/4256/1/CB1%20Receptor%20Blockade%20and%20its%20Impact_ocr.pdf","source":{"id":"https://openalex.org/S4306400651","display_name":"Open Repository and Bibliography (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Neuroendocrinology, 20 Suppl 1, 139-46 (2008)","raw_type":"http://purl.org/coar/resource_type/c_6501"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2826.2008.01681.x","doi":"https://doi.org/10.1111/j.1365-2826.2008.01681.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2826.2008.01681.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2826.2008.01681.x","source":{"id":"https://openalex.org/S100175869","display_name":"Journal of Neuroendocrinology","issn_l":"0953-8194","issn":["0953-8194","1365-2826"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neuroendocrinology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1994145229.pdf","grobid_xml":"https://content.openalex.org/works/W1994145229.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W97375214","https://openalex.org/W172874805","https://openalex.org/W1508039321","https://openalex.org/W1964607854","https://openalex.org/W1971036356","https://openalex.org/W1971698096","https://openalex.org/W1972117382","https://openalex.org/W1973217288","https://openalex.org/W1975227204","https://openalex.org/W1975317880","https://openalex.org/W1977055629","https://openalex.org/W1982657942","https://openalex.org/W1987669663","https://openalex.org/W1988368217","https://openalex.org/W1991334358","https://openalex.org/W1991778481","https://openalex.org/W1997236696","https://openalex.org/W2005136472","https://openalex.org/W2026530510","https://openalex.org/W2043356587","https://openalex.org/W2044160793","https://openalex.org/W2045245889","https://openalex.org/W2051424388","https://openalex.org/W2059479437","https://openalex.org/W2063051075","https://openalex.org/W2087587748","https://openalex.org/W2087674201","https://openalex.org/W2090246977","https://openalex.org/W2092554151","https://openalex.org/W2105565846","https://openalex.org/W2110203263","https://openalex.org/W2117507851","https://openalex.org/W2119754700","https://openalex.org/W2119826244","https://openalex.org/W2122487138","https://openalex.org/W2123907272","https://openalex.org/W2133811076","https://openalex.org/W2139634859","https://openalex.org/W2147568372","https://openalex.org/W2151669647","https://openalex.org/W2155725220","https://openalex.org/W2165284792","https://openalex.org/W2165611065","https://openalex.org/W2232408945","https://openalex.org/W3189565531","https://openalex.org/W4256701757","https://openalex.org/W4393311541"],"related_works":["https://openalex.org/W7028202226","https://openalex.org/W2232408945","https://openalex.org/W1523926970","https://openalex.org/W2151669647","https://openalex.org/W2059479437","https://openalex.org/W1979456416","https://openalex.org/W2097383437","https://openalex.org/W1991778481","https://openalex.org/W185146727","https://openalex.org/W2402735782"],"abstract_inverted_index":{"Rimonabant,":[0],"the":[1,15,132,205,241],"first":[2],"selective":[3],"CB(1)":[4],"receptor":[5],"antagonist":[6],"in":[7,14,17,63,91,102,106,112,119,131,139,144,157,225,246],"clinical":[8,27,197],"use,":[9],"has":[10,200],"been":[11],"extensively":[12],"investigated":[13],"Rimonabant":[16,39,137,175],"Obesity":[18],"(RIO)":[19],"programme,":[20],"comprising":[21],"four":[22],"1-2":[23],"year":[24,169],"placebo-controlled":[25],"randomised":[26],"trials":[28,236],"recruiting":[29],"more":[30],"than":[31],"6600":[32],"overweight/obese":[33,69,209],"patients":[34,92,123,247],"with":[35,79,98,124,159,180,194,211,216,248],"or":[36,121],"without":[37],"co-morbidities.":[38],"20":[40,95],"mg":[41,96],"daily":[42],"consistently":[43],"reduced":[44],"body":[45],"weight,":[46],"waist":[47],"circumference,":[48],"triglycerides,":[49],"blood":[50],"pressure,":[51],"insulin":[52],"resistance":[53],"and":[54,58,66,191,215,231],"C-reactive":[55],"protein":[56],"levels,":[57],"increased":[59],"HDL":[60,80],"cholesterol":[61,81,87],"concentrations":[62],"both":[64,228],"non-diabetic":[65],"type-2":[67,125,254],"diabetic":[68,146],"patients.":[70,147],"Adiponectin":[71],"levels":[72,88,116],"were":[73,89,170],"increased,":[74],"an":[75,127],"effect":[76,128],"that":[77],"correlated":[78],"augmentation,":[82],"while":[83],"small":[84],"dense":[85],"LDL":[86],"decreased":[90],"receiving":[93,100],"rimonabant":[94,199,245],"compared":[97,193],"those":[99],"placebo":[101],"RIO":[103,107],"Lipids.":[104],"Furthermore,":[105],"Diabetes,":[108],"a":[109,181],"0.7%":[110],"reduction":[111],"glycated":[113],"haemoglobin":[114],"(HbA1c)":[115],"was":[117,176],"observed":[118,166],"metformin-":[120],"sulphonylurea-treated":[122],"diabetes,":[126,255],"recently":[129],"confirmed":[130],"6-month":[133],"SERENADE":[134],"(Study":[135],"Evaluating":[136],"Efficacy":[138],"drug-NAive":[140],"DiabEtic":[141],"patients)":[142],"trial":[143],"drug-naive":[145],"Almost":[148],"half":[149],"of":[150,185,244],"metabolic":[151],"changes":[152],"occurred":[153],"beyond":[154],"weight":[155],"loss,":[156],"agreement":[158],"direct":[160],"peripheral":[161],"effects.":[162],"The":[163],"positive":[164],"effects":[165],"after":[167,172],"1":[168],"maintained":[171],"2":[173],"years.":[174],"generally":[177],"well-tolerated,":[178],"but":[179],"slightly":[182],"higher":[183],"incidence":[184],"depressed":[186],"mood":[187],"disorders,":[188],"anxiety,":[189],"nausea":[190],"dizziness":[192],"placebo.":[195],"In":[196],"practice,":[198],"to":[201,204,227,239],"be":[202],"prescribed":[203],"right":[206],"patient,":[207],"i.e.":[208,256],"subjects":[210],"cardiometabolic":[212,259],"risk":[213],"factors":[214],"no":[217],"major":[218],"depressive":[219],"illness":[220],"and/or":[221,253],"ongoing":[222],"antidepressive":[223],"treatment,":[224],"order":[226],"maximise":[229],"efficacy":[230],"minimise":[232],"safety":[233],"issues.":[234],"New":[235],"are":[237],"supposed":[238],"confirm":[240],"potential":[242],"role":[243],"abdominal":[249],"adiposity,":[250],"atherogenic":[251],"dyslipidaemia":[252],"at":[257],"high":[258],"risk.":[260]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}